期刊文献+

Stat3在部分相关皮肤病中的表达及意义

下载PDF
导出
摘要 信号传导及转录激活因子家族(signal transducer and activaye of transcription,Stat)是一类由生长因子、细胞因子等多肽类配体激活的转录因子。Stat是一类脱氧核糖核酸(DNA)结合蛋白,由750-850个氨基酸组成,分子量大小为90-113Kda.作为Janus激酶(Ja-nus Kinase,JAK)-Stat途径中JAK激酶的底物。
出处 《河北医学》 CAS 2012年第6期860-863,共4页 Hebei Medicine
基金 沧州市科技局项目寻常型银屑病皮损中Stat3 Survivin bFGF的表达及相关性研究 编号:1123031ZD
关键词 STAT3 银屑病 肿瘤
  • 相关文献

参考文献20

  • 1James NI. STATs:Signal transduction and activators of tran- scription[J]. Ce11,1996,84(2) :331-334.
  • 2James E, Darnell Jr. STATs and gene regulation [ J ]. Sci- ence, 1997,277 (12) : 1630-1635.
  • 3Yi Z ,James T, Christin C, et al. Activation of Stat3 in v-src- transformed fibroblasts requires cooperation of Jakl kinase activity [ J ]. Biol Chem, 2000, 275 (32) : 24935-24944.
  • 4王凤阳,常智杰.转录因子类癌基因——Stat3[J].生物化学与生物物理进展,2002,29(3):348-351. 被引量:6
  • 5Chakraborty A, Tweardy DJ. STAT3 and G- CSF- induced myeloid differentiation[ J ]. Leuk lymphoma, 1998,30 : 433 - 442.
  • 6Huaura EB, Turkson J, Jove R. Mechanisms of disease : In- sights into the emerging role of signal transduces and activa- tors of transcription in cancer [ J ]. Nat Clin Pract Oncol, 2005,2 (6) :315-324.
  • 7Cheng G, Lin J. Evaluation of potential cancer[ J]. Biochem Biophy Res Commun,2005, 335 (2) : 292-299.
  • 8Chan KS,Sano S, Kiguchi K,et al. Disruption of star3 revals a ritical role in both the initiation and the promotion stages of epithelial carcinogenesis [ J ]. Clin Invest, 2004, 114 : 720 - 728,.
  • 9Chan KS, Carbajal S, Kiguehi K, et al. Epidermal growth fac- tor Receptor-mediated activation of Stat3 during multistage skin carcinogenesis[ J ]. Cancer Res ,2004,64:2382-2389.
  • 10蔡绥勍,陈丽荣,王海军,姚丽芳,郑敏.磷酸化STAT3和p53基因在表皮肿瘤的表达[J].浙江大学学报(医学版),2004,33(4):331-334. 被引量:4

二级参考文献71

  • 1刘厚君,吴艳,林能兴,黄琨,李家文,古江增隆,涂亚庭.活化Stat 3和细胞周期蛋白D1蛋白在寻常性银屑病中的表达[J].中华皮肤科杂志,2006,39(9):509-511. 被引量:3
  • 2Nesterova M, Cho-Chung Y S. Killing the messenger:antisense DNA and siRNA [J]. Curr Drug Targets, 2004,5( 8 ) : 683-689.
  • 3Tamm I, Dorken B, Hartmann G. Antisense therapy in oncology: new hope for an old idea? [J]. Lancet, 2001,358 (9280) : 489-497.
  • 4Burke W M, Jin X, Lin H J, et al. Inhibition of constitutively active STAT3 suppresses growth of human ovarian and breast cancer cells [J]. Oncogene, 2001,20(55) : 7925-7934.
  • 5Leong P L, Andrews G A, Johnson D E, et al. Targeted inhibition of STAT3 with a decoy oligonucleotide abrogates head and neck cancer cell growth [J]. Proc Natl Acad Sci USA, 2003,100(7) :4138-4143.
  • 6Bowman T, Yu H, Sebti S, et al. Signal Transducers and activators of transcription: novel targets for anticancer therapeutics [ J ]. Cancer Control, 1999,6(5) : 427-435.
  • 7Yu H, Jove R. The STATs of cancer-new molecular targets come of age [J]. Nat Rev Cancer, 2004,4(2):97-105.
  • 8Bromberg J F, Wrzeszczynska M H, Devgan G, et al.STAT3 as an oncogene [ J ]. Cell, 1999,98 (3) : 295-303.
  • 9Niu G, Wright K L, Huang M, et al. Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis[J]. Oncogene, 2002,21 (13) :2000-2008.
  • 10Niu G, Shain K H, Huang M, et al. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest [ J ].Cancer Res, 2001,61 ( 8 ) : 3276-3280.

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部